NBGTX
Price
$29.61
Change
-$0.44 (-1.46%)
Updated
Jun 13 closing price
Net Assets
2.44B
RGAGX
Price
$78.43
Change
-$0.94 (-1.18%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

NBGTX vs RGAGX

Header iconNBGTX vs RGAGX Comparison
Open Charts NBGTX vs RGAGXBanner chart's image
Neuberger Berman Large Cap Growth Tr
Price$29.61
Change-$0.44 (-1.46%)
VolumeN/A
Net Assets2.44B
American Funds Growth Fund of Amer R6
Price$78.43
Change-$0.94 (-1.18%)
VolumeN/A
Net Assets306.22B
NBGTX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NBGTX vs. RGAGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBGTX is a StrongBuy and RGAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 306B vs. NBGTX (2.44B). RGAGX pays higher dividends than NBGTX: RGAGX (0.65) vs NBGTX (0.00). NBGTX was incepted earlier than RGAGX: NBGTX (32 years) vs RGAGX (16 years). NBGTX (1.01) is less costly to investors than RGAGX (0.30). NBGTX is a more actively managed with annual turnover of: 30.00 vs. RGAGX (25.00). NBGTX has a lower initial minimum investment than RGAGX: NBGTX (0) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : 7.67 vs. NBGTX (6.28). NBGTX (52.12) and RGAGX (51.11) have equivalent 5 years return.
NBGTXRGAGXNBGTX / RGAGX
Total Expense Ratio1.010.30337%
Annual Report Gross Expense Ratio1.010.30337%
Fund Existence32 years16 years-
Gain YTD2.1745.20542%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.44B306B1%
Annual Yield % from dividends0.000.650%
Returns for 1 year6.287.6782%
Returns for 3 years46.7054.6685%
Returns for 5 years52.1251.11102%
Returns for 10 years38.1375.6250%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX124.39-0.62
-0.50%
Neurocrine Biosciences
NMIH40.34-0.26
-0.64%
NMI Holdings
PMCB1.01-0.01
-0.99%
PharmaCyte Biotech
GSBC55.62-1.83
-3.19%
Great Southern Bancorp
CXDO5.14-0.36
-6.55%
Crexendo